Диссертация (1146691), страница 17
Текст из файла (страница 17)
7. P. 29-41.115.Gosse, P. Left ventricular hypertrophy as a predictor of cardiovascularrisk / P. Gosse// Journal of Hypertension, Supplement.- 2005.- Vol. 23, № 1.106116.Goyal, S.N. Impact of metabolic syndrome on re-stenosis develop-ment: Role of drug-eluting stents /S.N. Goyal [et al.]//Diabetes & VascularDisease Research.- 2012.- Vol. 9.- P 177-188.117.Granger, C. B. Outcome of patients with diabetes mellitus and acutemyocardial infarction treated with thrombolytic agents. The Thrombolysisand Angioplasty in Myocardial Infarction (TAMI) Study Group / C.B.Granger [et al.]// J Am Coll Cardiol.- 1993.- Vol.
21.- P. 920-925.118.Gruppetta, M. Long-term survival after acute myocardial infarctionand relation to type 2 diabetes and other risk factors / M. Gruppetta, S. Fava,N. Calleja// Clinical Cardiology.- 2010.- Vol. 33, № 7.- P. 424-429.119.Gyberg, V. Patients with coronary artery disease and diabetes needimproved management: a report from the euroaspire iv survey: a registryfrom the euroobservational research programme of the european society ofcardiology / V.
Gyberg [et al.]// Cardiovascular Diabetology.- 2015.- Vol.14, № 1.- P. 133.120.Haffner S. Metabolic syndrome — a new risk factor of coronary heartdisease?/ S.Haffner, H.B.Cassells // Diabetes, Obesity and Metabolism.2003.- Vol. 5, № 6.- P. 359-370.121.Han, T. S. Prospective study of c-reactive protein in relation to the de-velopment of diabetes and metabolic syndrome in the mexico city diabetesstudy / T. S.
Han, N. Sattar, K.Williams//Diabetes Care.- 2002.- Vol. 25, №11.- P. 2016-2021.122.Heeschen, C. Predictive value of C-reactive protein and troponin T inpatients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 antiplatelet therapy in unstable angina refractory tostandard treatment trial /C. Heeschen // J. Amer. Coll. Cardiology.- 2000.Vol. 35.- P. 1535-1542.107123.Herzum, M. Restenosis after percutaneous coronary interventions andinfection / M.
Herzum [et al.]// Herz.- 2000.- Vol. 25, № 2.- P. 91-94.124.Hirschfield, G. M. C-reactive protein and cardiovascular disease: newinsights from an old molecule / G. M. Hirschfield, M. B. Pepys// QJM: AnInternational Journal of Medicine.- 2003.- Vol. 96, № 11.- P. 793.125.Hobbs, F.D.R type 2 diabetes and metabolic syndrome patients: man-agement recommendations for reducing cardiovascular risk / F. D. R. Hobbs,E. Mcgregor, J.
Betteridge- Cardiovascular Risk Management, 2009.- 41-49p.126.Hoffmann, R. Impact of the Metabolic Syndrome on Angiographicand Clinical Events After Coronary Intervention Using Bare-Metal or Sirolimus-Eluting Stents /R. Hoffmann [et al.] //Am. J. Cardiol.- 2007.- Vol.100.- P. 1347-1352.127.http://www.gks.ru/wps/wcm/connect/rosstat_main/rosstat/ru/statistics/population/healthcare.128.Hyperinsulinemia: a link between hypertention obesity and glucose in-tolerance/ M. Modan [et al.]// J Clin Invest.- 1985.- Vol.
75.- P. 809-817.129.IDF Clinical Guidelines Task Force. Global guideline for Type 2 dia-betes. Brussels: International Diabetes Federation. -2005.130.Iribarren, C. Metabolic Syndrome and Early-Onset Coronary ArteryDisease/ Iribarren C. [et al] // J. of Amer. Coll. Cardiol. — 2006. -Vol. 48.— P. 1800-1807.131.Is insulin the link between hypertention and obesity?/ A. R. Cristlieb[et al]//Hypertention.- 1985.- Vol. 7.- P. 54-57.132.Ishihara, M.
Impact of acute hyperglycemia on left ventricular func-tion after reperfusion therapy in patients with a first anterior wall acute myo-108cardial infarction / M. Ishihara [et al.] // Am. Heart. J.- 2003.- Vol. 146.- P.674-678.133.Iturry-Yamamoto, G. R. Impact of metabolic syndrome and C-reactiveprotein on outcome after coronary stenting/ G. R. Iturry-Yamamoto [et al.]//J Endocrinol Invest.- 2009.-Vol. 32.- Р. 383-386.134.Kalantzi, K. The relative value of metabolic syndrome and cardiovas-cular risk score estimates in premature acute coronary syndromes / K.Kalantzi// American Heart Journal.- 2008.- Vol. 155, № 3.- P.
534-540.135.Kamp, O. Short, medium and lonqterm follow up after PTCA for sta-ble and unstable angina pectoris/ O. Kamp, K.J. Beatt, P. De Feyter// Am.Heart J.- 1989. –Р. 991−996.136.Kaplan, N. M. The deadly quartet: upper-body obesity, glucose intol-erance, hypertriglyceridemia and hypertension/ N. M. Kaplan// Arch InternMed.- 1989.- Vol. 149. P.
1514-1520.137.Keller, P.-F. Diabetes and acute coronary syndromes/ P.-F. Keller, D.Carballo, M. Roffi// Minerva Medicolegale.- 2010.- Vol. 101, № 2.- P. 81104.138.Kopelman, P. G. Obseity, non-insulin-dependent diabetes mellitus andthe metabolic syndrome / P. G. Kopelman, L. Albon// British Medical Bulletin.- 1997.-Vol. 53, № 2.- P.
322.139.Kosiborod, M. Glucometrics in Patients Hospitalized With Acute My-ocardial Infarction Defining the Optimal Outcomes-Based Measure of Risk/M. Kosiborod [et al.]// Circulation.- 2008.- Vol. 117.- P. 1018–1027.140.Kranjcec, D. Metabolic syndrome influencing infarct size and heartfailure in patients with acute coronary syndrome: does gender matter?/ D.Kranjcec, V.
Altabas// Endocr J.- 2012.-Vol. 59.- Р. 1065-1076.109141.Laakso, M. Insulin resistance and hyperglycaemia in cardiovasculardisease development / M. Laakso, J. Kuusisto// Nature Reviews Endocrinology.- 2014.- Vol. 10, № 5.- P. 293-302.142.Lakka, H.M. The metabolic syndrome and total and cardiovasculardisease mortality in middle-aged men/ Lakka H.M. [et al.] // JAMA. -2002. Vol. 288.
— P. 2709-2716.143.Landsberg, L. Diet, obesity, and hypertention: an hypothesis involvinginsulin, the sympathetic nervous system, and adaptive thermogenesis/ L.Landsberg//Q J Med.- 1986.- Vol. 61.- P. 1081-1090.144.Lavi, S. Hyperglycemia during acute myocardial infarction in patientswho are treated by primary percutaneous coronary intervention: impact onlong-term prognosi /S. Lavi [et al.]//International Journal of Cardiology.2008.- Vol. 123.- P. 117-122.145.Lee, J.-H.
Strategies for multivessel revascularization in patients withdiabetes / J.-H. Lee, S.-W. Lee// Journal of Comparative Effectiveness Research.- 2013.- Vol. 2, № 3.- P. 231-234.146.Lee, M. G. Impact of the metabolic syndrome on the clinical outcomeof patients with acute ST-elevation myocardial infarction/ M. G. Lee [etal]//J Korean Med Sci.- 2010.- Vol. 25.- P. 1456-1461.147.Lee, W.
L. Impact of diabetes on coronary artery disease in womenand men / W. L. Lee, A. M. Cheung, D. Cape// Diabetes Care.- 2000.- Vol.23, № 7.- P. 962-968.148.Lenzen, M. Diabetes known or newly detected, but not impaired glu-cose regulation, has a negative influence on 1-year outcome in patients withcoronary artery disease: a report from the euro heart survey on diabetes andthe heart / M.
Lenzen [et al.]//European Heart Journal.- 2006.- Vol. 27, №24.- P. 2969.110149.Liu, Y. Analysis of risk factors of cardiogenic shock secondary toacute myocardial infarction / Y. Liu [et al.]//Zhongguo Wei Zhong Bing JiJiu Yi Xue.- 2013.- Vol. 25, № 7.- P. 399-402.150.Lomuscio, A. Clinical correlation between diabetic and non diabeticpatients with myocardial infarction / A. Lomuscio [et al.]// Acta Cardiol.1991.- Vol.
46.- P. 543-554.151.Longo, G. Percutaneous drug-eluting stent implantation in diabetic pa-tients: short and long term outcomes from an observational study / G. Longo[et al.]// Minerva Cardioangiologica.- 2011.- Vol. 59, № 1.- P. 1-7.152.Long-term clinical outcome in the Bypass Angioplasty Revasculariza-tion Investigation Registry: comparison with the randomized trial. BARI Investigators/F. Feit [et al.]// Circulation. -2000.- Vol. 101.- P.
2795 — 2802.153.Ma, X. Metabolic syndrome in the prevention of cardiovascular dis-eases and diabetes — still a matter of debate?/ X. Ma, S. Zhu// EuropeanJournal of Clinical Nutrition.- 2013.- Vol. 67, № 5.- P. 518-521.154.Mehilli, Ju. Gender and restenosis after coronary artery stenting / Ju.Mehilli [et al.]// European Heart Journal.- 2003.- Vol. 24, № 16.- P.
1523.155.Metabolic syndrome clusters and the risk of incident stroke: the ather-osclerosis risk in communities (ARIC) study/ S.M. Rodriguez-Colon [etal.]// Stroke.- 2009.- Vol. 40.- P. 200-205.156.Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro As-sociazioni (PAMELA) study: daily life blood pressure, cardiac damage, andprognosis/ G. Mancia [et al.] //Hypertension.- 2007.- Vol. 49.- P.
40-47.157.Milazzo, D. Elevated levels of C-reactive protein before coronary ar-tery bypass grafting predict recurrence of ischemic events /D. Milazzo [etal.]// Amer. J. Cardiology.- 1999.- Vol. 84.- P. 459-461.111158.Milosz, D. Adiponectinemia, inflammatory process activity, and endo-thelial dysfunction in patients with type 2 diabetes and acute coronary syndrome with ST elevation in relation to the severity of lesions in the coronaryarteries/ D. Milosz [et al.]// Pol Arch Med Wewn.- 2007.- Vol. 117.- Р.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
